Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth.

Oshima T, Niwa Y, Kuwata K, Srivastava A, Hyoda T, Tsuchiya Y, Kumagai M, Tsuyuguchi M, Tamaru T, Sugiyama A, Ono N, Zolboot N, Aikawa Y, Oishi S, Nonami A, Arai F, Hagihara S, Yamaguchi J, Tama F, Kunisaki Y, Yagita K, Ikeda M, Kinoshita T, Kay SA, Itami K, Hirota T.

Sci Adv. 2019 Jan 23;5(1):eaau9060. doi: 10.1126/sciadv.aau9060. eCollection 2019 Jan.

2.

Non-coding RNAs: the gatekeepers of neural network activity.

Zampa F, Hartzell AL, Zolboot N, Lippi G.

Curr Opin Neurobiol. 2019 Aug;57:54-61. doi: 10.1016/j.conb.2019.01.006. Epub 2019 Feb 8. Review.

PMID:
30743177
3.

The circadian E3 ligase complex SCFFBXL3+CRY targets TLK2.

Correia SP, Chan AB, Vaughan M, Zolboot N, Perea V, Huber AL, Kriebs A, Moresco JJ, Yates JR 3rd, Lamia KA.

Sci Rep. 2019 Jan 17;9(1):198. doi: 10.1038/s41598-018-36618-3.

Supplemental Content

Loading ...
Support Center